New Therapy Helps Infant Stroke Survivors Gain Key Skills

Infants and toddlers who survived strokes are showing amazing progress thanks to a breakthrough therapy that's giving them a stronger start in life.

Researchers at 15 U.S. hospitals tested a new approach called I-ACQUIRE on 167 stroke survivors under age 3. The treatment gently restricts the use of their stronger arm with a lightweight cast while providing intensive, task-oriented physical therapy to strengthen the weaker side.

The results stunned scientists. Children receiving the high-dose version—six hours of therapy daily, five days a week for four weeks—gained an average of three new skills by the end of treatment. That's triple the improvement seen in kids receiving standard weekly therapy sessions.

Six months later, those gains held strong. Parents reported their children could do more everyday activities, from reaching for toys to feeding themselves, than they could before treatment.

"Now, we confidently know that this treatment, at both dosages, was well-received, safe and produced measurable benefits," said Dr. Sharon Ramey, who led the study at Virginia Tech's Fralin Biomedical Research Institute. Until now, doctors had little data to guide treatment decisions for babies this young.

The therapy happens right at home, making it easier for families to participate. Parents learn techniques to support their child's progress between sessions with certified therapists.

Why This Inspires

Perinatal stroke affects thousands of newborns each year, often leaving them with limited control on one side of their body. For decades, parents faced uncertainty about the best way to help their babies develop.

This research changes everything. Families now have proven options that work during a critical window when young brains are most adaptable and ready to rewire after injury.

Even better news: many children in the standard care group also showed significant improvement, suggesting that consistent therapy of any kind makes a real difference for these resilient little ones.

The study represents the first large-scale clinical trial focused specifically on infants and toddlers after perinatal stroke. Previous recommendations were based mostly on research involving older children with cerebral palsy, leaving a crucial knowledge gap.

These findings give doctors and parents the confidence to act early and aggressively, knowing the treatment is both safe and effective for babies as young as eight months old.